Prostate Cancer Companies in BioPortfolio's Corporate Database - Page: 3
Prostate Cancer company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Prostate Cancer companies that have been added to our website.
Search For More Prostate Cancer Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Prostate Cancer Companies.
More Information about Prostate Cancer on BioPortfolio
We have published hundreds of Prostate Cancer news stories on BioPortfolio along with dozens of Prostate Cancer Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Prostate Cancer for you to read.
Showing "prostate" Companies 51 to 75 of 135
Calypso Medical Technologies, Inc.
Calypso Medical Technologies, Inc. is a Seattle-based, privately held medical device company. The Companyâs proprietary tumor localization system utilizes miniaturized implanted devices (Beacon electromagnetic transponders) to continuously, accurately and objectively track the location of tumors for improved accuracy and management of radiation therap...
Aduro BioTech is a clinical-stage immunotherapy company developing novel and potent vaccines based on Listeria monocytogenes. The company has engineered two distinct Listeria vaccine platforms to be safe for use in humans while continuing to induce robust immune responses. These advances have been published in 20 major studies and have generated more than...
AmpliMed Corporation develops novel drugs for the treatment of cancer. Our lead product, Amplimexon™ (imexon inj.), has particular promise for the treatment of pancreatic cancer, malignant melanoma, lung cancer and multiple myeloma. Other products in our portfolio have promise in ovarian, breast, prostate and other common cancers. Our compounds have novel ways of killing cancer cells which are d...
Through the Power of Our People, and in accordance with the AdvaMed Code of Ethics, we continue to develop new therapies to restore bodily functions and to enable people to regain control of their lives. These therapies are often inspired by the urologists, gynecologists and urogynecologists who choose AMS as their solutions partner ... truly the Surgeon's Choice. Several of our treatments are so...
Henry Ford Hospital, a 802-bed tertiary care hospital, education and research complex in Detroitâs New Center Area, is the flagship hospital for Henry Ford Health System. The Henry Ford Vattikuti Urology Institute is the leading prostate cancer program in the world where patients have access to the some of the most innovative technology and treatment...
MabCure is a biotechnology company whose vision is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs), which we plan to develop as diagnostic tools, imaging agents, and drugs to treat lethal cancers. MabCureâs initial g...
American Medical Systems Holdings, Inc.
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect s...
Gamma Labs, a division of Gamma Enterprises, LLC, is a company dedicated to supplying its customers with natural supplements which are based on the latest science and manufactured to the highest levels of pharmaceutical standards. Founded in 2004, Gamma Labsâ mission is to deliver proven, natural supplements which set up a foundation for peak performa...
The Prostate Cancer Foundation
The Prostate Cancer Foundation is the worldâs largest philanthropic source of support for prostate cancer research focused on discovering better treatments and a cure for prostate cancer at every stage of diagnosis. Founded in 1993, the PCF has raised more than $370 million and provided funding to more than 1,500 research projects at nearly 200 instit...
Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedicating itself to collaborative relationships with the healthcare community to translate cancer discovery and research into better patient care. Clarient's principal customers include pathologists, onco...
ZERO - The Project to End Prostate Cancer
On July 1, 2003, a merger between two innovative leaders in prostate cancer treatments set the standard for minimally invasive options. The merger between Amersham Health (now GE Healthcare)–Therapy Business, the leader in brachytherapy and Galil Medical’s Urology Business, the innovator in cryotherapy procedures was finalized. This formed a new company combining both our people and products e...
Ultra-high resolution cryo-surgical device. FDA-approved and effective for prostate cancer, liver cancer and many other applications. System uses needle-probes (1.5mm) to directly freeze localized tissue. 2mm and 3mm probes are available for use in conjunction with IMRI. Galil offers full technical and clinical support for our new-generation cryo system.
Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics is a biotechnology company focused on developing immunotherapy products to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis. The Company has two broad platform technologies: dendritic cell-based vaccines and therapeutic antibodies. The Company is focusing on development...
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in...
EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...
ProUroCare Medical, Inc. is a publicly traded company engaged in the business of developing innovative medical imaging products. The company's current focus is the ProUroScan prostate imaging system, which is used to document abnormalities of the prostate detected by a Digital Rectal Exam (DRE). Based in Minneapolis, Minn., ProUroCare's common stock is quoted on the OTCBB.
American Medical Systems, Inc.
American Medical Systems, headquartered in Minnetonka, Minnesota, is a diversified supplier of medical devices and procedures to cure incontinence, erectile dysfunction, benign prostate hyperplasia (BPH), pelvic floor repair and other pelvic disorders in men and women. These disorders can significantly diminish one's quality of life and profoundly affect social relationships. In recent years, the...
Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute...
Each year thousands of patients from around the world and across the United States turn to RC Cancer Centers seeking a cure for their prostate cancer and learn why they are The Choice for Saving Lives. Founded in 1979, Radiotherapy Centers of Georgia, a division of RC Cancer Centers, has earned a reputation for being one of the country's top cancer treatment and research facilities because of its...
PharmaMar is Grupo Zeltia's biotechnology subsidiary; it is a world leader in discovering, developing and selling marine-based drugs to treat cancer. Yondelis(R) is Spain's first anti-cancer drug. It is currently approved for soft tissue sarcoma (STS) in 25 countries outside the EEA, and in 5 of those countries for platinum-sensitive recurrent ovarian cancer (ROC) as well. Yondelis(R) is approved...
NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer.The successful completion of the Human Genome Project signals a new age in medical discovery centered on protein research. The rapidly growing knowledge base of the human genome provides an unprecedented opportunity to launch a revolutionary paradigm...
USHIFU, LLC (US HIFU), a privately held healthcare company, is a world leader in minimally invasive high intensity focused ultrasound (HIFU) technologies. US HIFU manufactures the Sonablate® 500 medical device and is focused currently on treating primary and recurrent prostate cancer using Sonablate® HIFU. The company is engaged in ongoing research for technological advancements for the Sonablat...
Founded in 2000, AndroScience Corporation (ASC) is developing two novel small molecule platforms based on the therapeutic targets of the androgen receptor (AR) and select members of the Signal Transducer and Activator of Transcription (STAT) signaling pathway. The first patented family of compounds function through the enhancing degradation of AR protein, a novel mechanism of action described as A...
Pfizer Oncology is committed to the discovery, investigation and development of innovative treatment options to improve the outlook for cancer patients worldwide. Our strong pipeline, one of the most robust in the industry, is studied with precise focus on identifying and translating the best scientific breakthroughs into clinical application for patients across a wide range of cancers, including...
